Inovio's planned Phase 2/3 Covid-19 vaccine trial on partial hold to answer FDA questions, company says

  • 📰 CNN
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 95%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

Inovio's planned Phase 2/3 Covid-19 vaccine trial has been put on partial hold to answer questions from the FDA, biotechnology company says.

From CNN's Stephanie Halasz in London and Pierre Bairin in Paris

Coronavirus admissions at intensive care units in the Provence-Alpes Côte d'Azur region of southern France have tripled since the beginning of September, according to official statistics. The number of Covid-19 ICU patients in Paris went up from 169 to 339 in the same period. In France overall, the figure went up to 1,112 by September 27 compared to 418 at the start of the month, the health authority says.

The situation in the south of France will be reviewed after seven days, and could be extended by a further week if there is no improvement, the French Health Minister tweeted.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.

why would the FDA put a hold on Inovio INO-4800 vaccine delivering device when the vaccine has been proven to be safer and more effective then any others, its because Big Pharma has corrupted the officials at the FDA. This screams of foul play. InovioPharma inoviolt

BREAKING: Democrat Party activists pretending to report the news are intentionally neglecting to inform the public of any wrongdoing by key Democrat leadership figures and their family. ONLY PRESIDENT TRUMP IS TARGETED BY THE MEDIA.

Since cnn won't report...

horrible

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 4. in SE

Sverige Senaste nytt, Sverige Rubriker